Ketamine administration in depressive disorders: A systematic review and meta-analysis

Psychopharmacology

Volumn 231, Issue 18, 2014, Pages 3663-3676

  Fond, Guillaume ^a,e   Loundou, Anderson ^b   Rabu, Corentin ^a   Macgregor, Alexandra ^c   Lançon, Christophe ^b   Brittner, Marie ^c   Micoulaud Franchi, Jean Arthur ^b   Richieri, Raphaelle ^b   Courtet, Philippe ^c   Abbar, Mocrane ^d   Roger, Matthieu ^a   Leboyer, Marion ^a   Boyer, Laurent ^b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b TIMONE HOSPITAL   (France)

^c INSERM U1061   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

^e Hopital Albert Chenevier   (France)

Author keywords

Bipolar disorder; Electroconvulsive therapy (ECT); Ketamine; Major depression; Resistant

Indexed keywords

KETAMINE; PLACEBO; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT;

ANESTHESIA INDUCTION; BIPOLAR DEPRESSION; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; DISORIENTATION; DISSOCIATIVE DISORDER; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; ELEVATED BLOOD PRESSURE; HUMAN; HYPERTENSION; HYPOMANIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MANIA; META ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; REVIEW; SUICIDAL IDEATION; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; XEROSTOMIA; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT;

ANESTHETICS, DISSOCIATIVE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; HUMANS; KETAMINE;

EID: 84906937722     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3664-5     Document Type: Review

References (35)

1. Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R (2012) Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT 28:157-161
2. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354 (Pubitemid 30109248)
3. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, Chichester
4. Brewer CL, Davidson JR, Hereward S (1972) Ketamine ("Ketalar"): a safer anaesthetic for ECT. Br J Psychiatry 120:679-680
5. Calabrese JR, Huffman RF, White RL, Edwards S, Thompson TR, Ascher JA, Monaghan ET, Leadbetter RA (2008) Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 10:323-333 (Pubitemid 351637697)
6. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Scientific Advisory B, the Executive Committee of the Grand Challenges on Global Mental H, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V, Sahakian BJ, Saxena S, Singer PA, Stein DJ (2011) Grand challenges in global mental health. Nature 475:27-30
7. Cusin C, Hilton GQ, Nierenberg AA, Fava M (2012) Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. Am J Psychiatry 169:868-869
8. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
9. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793-802
10. Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, Afzali MH (2014) Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res 215:355-361
11. Green CD (1973) Ketamine as an anaesthetic for ECT. Br J Psychiatry 122:123-124
12. Gross RA, Johnston KC (2009) Levels of evidence: taking neurology to the next level. Neurology 72:8-10
13. Harihar C, Dasari P, Srinivas JS (2013) Intramuscular ketamine in acute depression: a report on two cases. Indian J Psychiatry 55:186-188
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560 (Pubitemid 37088507)
15. Higgins JPT, Altman DG, Sterne JAC (2011) Assessing risk of bias in included studies. In J. P. T. Higgins, & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration
16. Jarventausta K, Chrapek W, Kampman O, Tuohimaa K, Bjorkqvist M, Hakkinen H, Yli-Hankala A, Leinonen E (2013) Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study. J ECT 29:158-161
17. Kitagawa H, Yamazaki T, Akiyama T, Mori H, Sunagawa K (2001) Effects of ketamine on in vivo cardiac sympathetic nerve endings. J Cardiovasc Pharmacol 38(Suppl 1):S39-S42 (Pubitemid 33104682)
18. Kranaster L, Hoyer C, Janke C, Sartorius A (2011) Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia. World J Biol Psychiatry
19. Krystal AD, Weiner RD, Dean MD, Lindahl VH, Tramontozzi LA 3rd, Falcone G, Coffey CE (2003) Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci 15:27-34 (Pubitemid 36168076)
20. Kudoh A, Takahira Y, Katagai H, Takazawa T (2002) Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95:114-118 (Pubitemid 34705563)
21. Loo CK, Katalinic N, Garfield JB, Sainsbury K, Hadzi-Pavlovic D, MacPherson R (2012) Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord 142:233-240
22. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
23. McDaniel WW, Sahota AK, Vyas BV, Laguerta N, Hategan L, Oswald J (2006) Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT 22:103-106 (Pubitemid 44491108)
24. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
25. Morgan CJ, Curran HV (2011) Ketamine use: a review. Addiction 107:27-38
26. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CM, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry
27. Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T (2010) Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT 26:223-227
28. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905-1917 (Pubitemid 44807782)
29. Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenicek T (2013) Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinol Lett 34:287-293
30. Souery D, Papakostas GI, Trivedi MH (2006) Treatment-resistant depression. J Clin Psychiatry 67(Suppl 6):16-22 (Pubitemid 44078108)
31. Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, Krystal JH, Sanacora G (2011) The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 191:122-127
32. Vassos E, Collier DA, Fazel S (2013) Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry
33. Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C (2012) Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT 28:128-132
34. Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA (2012) Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry
35. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864 (Pubitemid 44188478)